Literature DB >> 3226727

Molecular cloning and characterization of human ret-II oncogene.

Y Ishizaka1, T Tahira, M Ochiai, I Ikeda, T Sugimura, M Nagao.   

Abstract

A transformant having ret-II was obtained by transfection of NIH3T3 cells with DNA from a human sigmoid colon cancer. Comparison of the restriction map of ret-II with that of proto-ret revealed that the ret-II has rearrangements both 5' and 3' to the sequence coding for the kinase domain. However, only the upstream rearrangement was consistently observed in all transformants, suggesting that the upstream rearrangement resulted in the activation of proto-ret. The recombination point and replaced sequence of ret-II were different from those previously reported for ret (Takahashi et al., 1985). In addition, ret-II does not retain region coding for transmembrane of proto-ret. This rearrangement, however, was not detected in the original tumor DNA by Southern blot analysis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3226727

Source DB:  PubMed          Journal:  Oncogene Res        ISSN: 0890-6467


  8 in total

Review 1.  Translocations in epithelial cancers.

Authors:  J Chad Brenner; Arul M Chinnaiyan
Journal:  Biochim Biophys Acta       Date:  2009-05-04

2.  Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase.

Authors:  G A Rodrigues; M Park
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

3.  Deletion of transfected oncogenes from NIH 3T3 transformants by inhibitors of poly(ADP-ribose) polymerase.

Authors:  M Nakayasu; H Shima; S Aonuma; H Nakagama; M Nagao; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

4.  Flat reversion by okadaic acid of raf and ret-II transformants.

Authors:  R Sakai; I Ikeda; H Kitani; H Fujiki; F Takaku; U Rapp; T Sugimura; M Nagao
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

5.  An epidermal growth factor receptor/ret chimera generates mitogenic and transforming signals: evidence for a ret-specific signaling pathway.

Authors:  M Santoro; W T Wong; P Aroca; E Santos; B Matoskova; M Grieco; A Fusco; P P di Fiore
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

6.  Expression of ret proto-oncogene in human neuroblastomas.

Authors:  M Nagao; Y Ishizaka; A Nakagawara; K Kohno; M Kuwano; T Tahira; F Itoh; I Ikeda; T Sugimura
Journal:  Jpn J Cancer Res       Date:  1990-04

Review 7.  RET signaling pathway and RET inhibitors in human cancer.

Authors:  Angelina T Regua; Mariana Najjar; Hui-Wen Lo
Journal:  Front Oncol       Date:  2022-07-25       Impact factor: 5.738

8.  Presence of aberrant transcripts of ret proto-oncogene in a human papillary thyroid carcinoma cell line.

Authors:  Y Ishizaka; F Itoh; T Tahira; I Ikeda; T Ogura; T Sugimura; M Nagao
Journal:  Jpn J Cancer Res       Date:  1989-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.